Imprimis Pharmaceuticals Signs Agreement with Specialty ...

PR Newswire (press release)-4 hours ago

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded ...

Imprimis Pharmaceuticals Inc. (IMMY) to Release Earnings on Monday
The Cerbat Gem-5 hours ago

View all